Impact of Institutional Practices and Surgical Complexity on Sarcoma Surgery Costs: Driving Efficiency in Value-Based Healthcare.
Georg SchellingPhilip HeesenBoris TautermannMarkus WepfBarbara Di FedericoAnnika FreiKim van OudenaardePietro GiovanoliBeata Bode-LesniewskaGabriela StuderMario F Scaglioninull On Behalf Of The Swiss Sarcoma NetworkPublished in: Cancers (2024)
The study underscores the need for standardized cost assessment practices and highlights the potential of predictive models in enhancing resource allocation and surgical planning. By advocating for value-based healthcare models and standardized treatment guidelines, this research contributes to more equitable and sustainable healthcare delivery for sarcoma patients. These insights affirm the necessity of including a full spectrum of care costs in value-based models to truly optimize healthcare delivery. These insights prompt a reevaluation of current policies and encourage further research across diverse geographical settings to refine cost management strategies in sarcoma treatment.
Keyphrases
- healthcare
- end stage renal disease
- primary care
- chronic kidney disease
- public health
- newly diagnosed
- ejection fraction
- palliative care
- combination therapy
- clinical practice
- prognostic factors
- quality improvement
- chronic pain
- coronary artery disease
- replacement therapy
- surgical site infection
- acute coronary syndrome
- human health
- patient reported